Metal-Based Thiophene Photodynamic Compounds for DNA Cleavage
Solution Overview
Problem
Current photodynamic compounds for treating diseases associated with unwanted and/or hyperproliferating cells, such as cancer, lack photostability, effective activation wavelengths, and oxygen-independent functionality, particularly in hypoxic environments, and fail to target intracellular nuclear DNA effectively.
Innovation Solution
Development of novel tunable metal-based thiophene photodynamic compounds that can be activated by visible light to cleave DNA, functioning through Type 1 or Type 2 photoprocesses, with enhanced photostability, red-light or NIR absorption, and ability to target intracellular nuclear DNA regardless of oxygen levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional organic-based porphyrins are used as photodynamic compounds, then they can be activated with relatively short wavelengths of light, but they do not function in hypoxic environments and lack photostability
Solution Approach 1:
The patent changes the chemical composition parameters by introducing metal-based complexes (ruthenium, rhodium, and other metal centers) with specific ligand structures. These parameter changes enable the compounds to function in hypoxic environments while maintaining photostability and providing activation at red-light and NIR wavelengths, thus resolving the contradiction between reliability in hypoxic conditions and adaptability in activation wavelength range
Solution Approach 2:
The patent employs composite material structures by combining metal centers with organic ligands (such as porphyrins, phthalocyanines, and other coordinated ligands) to create hybrid photodynamic compounds. These composite structures integrate the advantages of both metal complexes (photostability, hypoxia functionality) and organic compounds (light absorption properties), enabling simultaneous achievement of reliability in hypoxic environments and versatility in activation wavelengths
2Illumination intensity
If photodynamic compounds are designed for red-light or NIR absorption, then activation wavelength is improved, but absorption intensity at activation wavelength may be reduced
Solution Approach 1:
The patent optimizes molecular parameters including metal center selection (ruthenium, rhodium, osmium, etc.), ligand field strength, and molecular geometry to achieve optimal balance between absorption intensity and photostability. By adjusting these parameters, the compounds exhibit strong absorption in the red-light and NIR regions while maintaining high photostability required for therapeutic application
Solution Approach 2:
The patent introduces specific local structural features such as extended conjugation in ligand systems, metal-to-ligand charge transfer (MLCT) states, and specific coordination geometries that locally enhance absorption intensity at target wavelengths while preserving overall molecular photostability. This local optimization allows simultaneous achievement of strong red-light/NIR absorption and high photostability
3Productivity
If photodynamic compounds target intracellular nuclear DNA, then therapeutic effectiveness is improved, but selectivity and potential off-target effects become concerns
Solution Approach 1:
The patent incorporates specific local structural features in the photodynamic compounds, such as planar aromatic ligand systems (porphyrins, phthalocyanines) that enable intercalation between DNA base pairs, and positively charged metal centers that facilitate electrostatic interaction with the negatively charged DNA backbone. These localized structural properties provide selective DNA targeting while the overall molecular design controls off-target interactions through size, charge distribution, and cellular uptake mechanisms
Solution Approach 2:
The patent employs the photodynamic compound itself as an intermediary that mediates between the activating light and the DNA target. The compound accumulates in cells, selectively localizes to the nucleus, and upon light activation, generates reactive species that cleave DNA. This intermediary approach provides spatial and temporal control, improving therapeutic effectiveness while reducing off-target effects by confining the photochemical action to illuminated regions
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds demonstrate increased photodynamic activity, efficient DNA targeting, and functionality in both normoxic and hypoxic conditions, offering a potent therapeutic and diagnostic tool for treating hyperproliferating cells and pathogens.
Implementation Method 1
Metal-based thiophene photodynamic compounds that can be activated to cleave DNA upon irradiation with visible light by either a Type 1 or Type 2 photoprocess
Data Source
AI summary
Compositions of the invention include tunable metal-based thiophene photodynamic compounds useful as therapeutic agents and as in vivo diagnostic agents for treating or preventing diseases that involve unwanted and/or hyperproliferating cell etiology including cancer and diseases associated with unwanted and/or hyperproliferating cells. The compositions are also useful for treating infectious diseases and for pathogen disinfection and/or sterilization.